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Abstract
Background: Recent studies show that the expression of inflammatory mediators, such as cytokines, is an important 
factor for the development and progression of heart failure (HF), especially in the presence of left ventricular dysfunction. 
These changes have been demonstrated both in the plasma and heart muscle and, more recently, in skeletal muscle of 
rats and in patients with HF. 
Objective: To investigate the production and expression of tumor necrosis factor-α (TNF) and interleukin-10 (IL-10) in 
the soleus and the extensor digitorum longus (EDL) muscles of animals with left ventricular dysfunction after myocardial 
infarction (MI). 
Methods: We used male Wistar rats that underwent ligation of the left coronary artery without reperfusion. Four weeks 
after this procedure, the animals underwent echocardiography and were divided into the following experimental groups: 
sham operated (sham) and IM. They remained under observation for a further period of 8 weeks. 
Results: The level of the cytokine TNF-α increased by 26.5% (p <0.05), and its gene expression increased 3 times (p 
<0.01). The level of IL-10 decreased by 38.2% (p <0.05). Both changes occurred only in the soleus muscle, with no 
change in the EDL. The decrease (36.5%, p <0.05) in the IL-10/TNF-α ratio was due to both increased tissue levels of 
TNF-α and decreased tissue levels of IL-10. 
Conclusion: Our results showed significant changes in the IL-10/TNF-α ratio, which may have an additive role in the 
assessment of deterioration and progression of left ventricular dysfunction post-MI. Furthermore, our study suggests 
that these changes seem to be related to the muscle fiber type. (Arq Bras Cardiol 2010; 94(3):293-300)
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Introduction 
Heart failure (HF) is a clinical syndrome of complex 
pathophysiology that may result from any structural or 
functional disorder that strikes the heart and consequently 
undermines the ability of the ventricles to satisfactorily fill and 
pump blood1,2. The cardinal manifestations of HF are dyspnea 
and fatigue, which may limit the ability to perform physical 
activity (exercise intolerance) and culminate in processes 
leading to pulmonary and systemic congestion and increased 
peripheral vascular resistance1,3. The main causes of HF of 
cardiac origin are coronary artery disease, high blood pressure, 
dilated cardiomyopathy and heart valve diseases1,4. 
Currently, the deteriorative changes involved in the 
progression of HF with left ventricular dysfunction do not 
depend only on hemodynamic parameters, but also on 
the processes that culminate in local (heart) and systemic 
inflammatory activation5-7, which are evidenced by the increase 
in both gene and protein expression of pro-inflammatory 
cytokines, such as: tumor necrosis factor (TNF-α), interleukin 
1β (IL-1β), and interleukin 6 (IL-6), among others. These 
changes have been demonstrated both in plasma and in 
skeletal and heart muscles of rats and patients with HF. These 
inflammatory mediators may contribute to the pathophysiology 
and progression of HF, and also directly influence the onset 
of clinical manifestations of the HF syndrome, particularly 
the changes related to the reduction and the functioning of 
muscle mass8,9.
Therefore, although in recent years the vast majority of 
studies on HF have focused on pro-inflammatory cytokines, 
the anti-inflammatory cytokines, especially IL-10, have 
currently gained prominence and may have an important 
role in the pathophysiology of HF10,11. In patients with HF, and 
especially in cases of left ventricular dysfunction, a decrease 
in plasma IL-10 has been reported and is positively correlated 
with a decline in the left ventricular ejection fraction.12 
Moreover, in animals with post-MI HF, the production ratio 
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of IL-10 and TNF-α (IL-10/TNF-α ratio) has recently been 
demonstrated as a more accurate indicator of the degree of 
ventricular dysfunction12. 
In fact, in animal models and patients with HF, the 
distribution of muscle fibers into type I (aerobic), type IIa 
(aerobic and anaerobic) and type IIb (anaerobic) undergoes 
changes in its composition. Notably, the skeletal muscle fibers 
type I are the most affected, because they develop some 
characteristics similar to the type IIA13, besides a reduction in 
capillary density3 and a reduction in the maximum activity of 
the enzyme cytochrome c oxidase9, in comparison to the same 
muscle fiber type in individuals without pathological changes 
in skeletal muscle. Similarly, studies in rats with post-MI left 
ventricular dysfunction have reproduced this  behavior14, 
showing thereby that the type I fibers in skeletal muscle seem 
to be the most affected in this condition. 
Furthermore, these changes have been correlated to the 
increase in gene expression and production of cytokines 
(TNF-α, IL-1β, and IL-6) in the quadriceps muscle of humans15 
and animals7. Although the deleterious changes occur 
predominantly in type I fibers, recent studies have shown the 
presence of a chronic inflammatory condition in that tissue. 
However, to date, no studies have evaluated the production 
of these cytokines in the different muscle fiber types, a fact 
that becomes even more significant when we consider that 
this tissue may be an important systemic “supplier” of pro-
inflammatory cytokines in the presence of left ventricular 
dysfunction. In turn, the analysis of the gene expression 
and the consequent production of these cytokines may be 
a more accurate and/or additional indicator of the presence 
of changed chronic inflammatory markers in ventricular 
dysfunction. 
On this basis, we proposed to study the relationship 
between the levels of pro-TNF-α cytokines and anti-
inflammatory (IL-10) cytokines in skeletal muscle in an 
experimental model in rats with post-MI left ventricular 
dysfunction. Still, we used the soleus muscle (fiber type I, 
predominantly) and the extensor digitorum longus (EDL) 
muscle (fiber type IIb, predominantly) to compare the profiles 
of these cytokines in different muscle types. 
Methods 
Animals 
The experimental procedures were in accordance with 
the ethical principles for animal experimentation adopted 
by the Brazilian College of Animal Experimentation (Cobea), 
and the protocol for the use of animals in experimentation 
(009/2005) was approved by the Animal Experimentation 
Ethics Committee (Ceea) at a meeting held on February 
17th, 2005. 
We used male Wistar rats aged 8 weeks. During the 
experimental period, they were kept in collective cages for 
5 mice, in a vivarium with a light/dark cycle of 12/12 hours, 
with the light phase starting at 7 am, in the Department of 
Cell Biology and Development of the Institute of Biomedical 
Sciences of the University of São Paulo. Room temperature 
was maintained at 25 ± 2° C. Humidity was maintained at 60 
± 5%. All groups received a balanced commercial diet (Nuvilab 
CR1 - Nutrivital Nutrients Ltda.) and water ad libitum. In order 
to minimize the acute influence of the prandial status in the 
experimental results, all animals were fasted overnight before 
the morning sacrifice. 
Induction of acute myocardial infarction (MI) by myocardial 
injury through ischemia without reperfusion
This surgical procedure was performed using the techniques 
of the exercise and cellular physiology laboratory (KCM 
or MAC). The animals were anesthetized with a solution 
of Ketalar ® (80 mg/kg) + Rompun ® (12 mg/kg). After 
intubation, the animals received mechanical ventilation 
with a Harvard ventilator, model 683 (frequency of 90 m/
min, and tidal volume of 2.0 ml). After shaving the chest, 
a left thoracotomy was performed in the intercostal space 
of the apex beat, and the heart was quickly exposed. The 
anterior interventricular branch of the left coronary artery was 
identified and ligated between the edges of the left auricular 
appendage and the pulmonary artery with 6-0 prolene sutures. 
The lungs were hyperinflated, and the chest wall was closed 
with a previously performed purse-string suture. For the sham 
operation, we used the same surgical procedure but without 
the disruption of the pericardium and the ligation of the left 
anterior descending coronary artery. 
After the coronary artery ligation, the animals were 
confined to the vivarium for 3 more weeks. By the fourth 
week, an echodopplercardiogram (ECHO) was performed to 
confirm the presence of infarction, to evaluate its size, and 
to conduct echocardiographic measurements, including left 
ventricular ejection fraction. 
Transthoracic doppler echocardiography 
During 4 and 12 weeks after MI, the animals were 
anesthetized with a solution of Ketalar ® (50 mg/kg) + Rompun 
® (10 mg/kg) intraperitoneally for echocardiography. 
The echocardiography was performed in an HP Sonos 
5500 (Hewlett Packard, Andover, MA, USA) using a 
transducer fundamental frequency of 12 MHz, to obtain 
images at 2 cm depth. After anesthesia and using the same 
procedure, the animals were placed in the left lateral 
position, and three electrodes were placed in their legs for 
the electrocardiogram. 
Cross-sectional scans of the left ventricle were recorded 
on videotape for later analysis. We used the left paraesternal 
(longitudinal and transverse) and the apical (four and two 
chambers) views. The linear measurements taken from images 
obtained by M-mode were: LV diameters at end-diastole 
(LVDD) and systole (LVSD); the anteroposterior diameter of 
the left atrium (LA); and the diameter of the anterior wall 
of the left ventricle in diastole (Paved). The infarction size 
(% MI), assessed by measuring the length of the akinetic 
and/or hypokinetic (AHR) regions of the ventricular walls, 
was expressed as a percentage of the total perimeter of the 
endocardial contour (EP) in three transverse LV views (level 
of the edges of the leaflets of the mitral valve, papillary 
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muscles, and apical region), according to earlier patterning 
characterized by the group of Professor Paul J. F. Tucci16,17, 
using the formula: MI (%) = (AHR / EP) x 100. 
The cardiac function was evaluated by the ejection fraction 
(EF). The ventricular diastolic (DV) and systolic (SV) volumes 
were obtained using the Simpson biplane (apical, four and two 
chambers) method, and the EF was calculated by the formula 
EF = (DV-SV/DV) x 100. The diastolic function was assessed 
using indices derived from the velocity curve of the mitral 
diastolic flow obtained by the pulsed Doppler technique. We 
obtained the velocity curve of the mitral diastolic flow from the 
apical four-chamber view, placing the sample volume close 
to the ventricular face of the mitral valve. We determined 
the E wave, the A wave, and the E/A ratio. At the end of the 
ECHO assessment, the animals in which the MI was greater 
than 40% of the LV were selected for the group of myocardial 
infarction (MI). After 12 weeks, the animals in the MI group 
were reevaluated as to the aforementioned parameters.
Experimental design 
After the echocardiography, the animals were divided into 
two experimental groups: sham operated (sham, n = 13) and 
myocardial infarction (MI, n=17). The sham group animals 
underwent all surgical procedures except the coronary artery 
ligation. After this, the animals were kept for 8 weeks under 
observation. Following this period, the animals were sacrificed 
by decapitation without anesthesia. 
Collection and homogenization of tissues 
Immediately after sacrifice, tissues and organs (liver, lungs, 
heart, soleus and extensor digitorum longus-EDL muscles) 
were removed, weighed, frozen in liquid nitrogen, and stored 
at -80° C for subsequent measurements. 
Quantification of tissue cytokines 
For measurement of TNF-α (DY510) and IL-10 (DY522) 
cytokines, we used the enzyme-linked immunoabsorbent 
assay (DuoSet ELISA) capture method (R&D System, Inc., 
Minneapolis, USA). This assay was performed on homogenized 
samples from the different experimental groups, according 
to the standards described by the manufacturer. The results 
are expressed in pg/μg of total protein in the assessed 
tissues according to the colorimetric method described by 
Bradford18. 
Quantification of tissue cytokine gene expression 
To isolate total RNA from the EDL and the soleus muscles 
(right hindpaw), samples weighing between 0.2 and 0.5g 
were homogenized in TRIZOL® Reagent, according to 
the standards described by the manufacturer19. The RNA 
samples were transcribed to DNA in a thermocycler (Techne, 
Cambridge, UK). To synthesize cDNA, we used 2μg of total 
RNA from each sample. The samples were incubated with 
0.5 μg/ml of oligo DT12-18 (Invitrogen, USA) at 65° C, for 5 
minutes, to obtain the first tape of cDNA. 
Primers were synthesized by Integrated DNA Technologies 
(Prodimol Biotecnologia S/A). The sequence was determined 
using the software Primer 3, available at http://www.genome.
wi.mit.edu. Primers were selected in accordance with the 
following parameters described by Marone et al20: TNF-α (NM 
012675.2); sense: 5`TCT CAA AAC TCG AGT GAC AAG C 3`; 
anti-sense: 5`GGT TGT CTT TGA GAT CCA TGC3`; IL-10 (NM 
012854.1), sense: 5`GAG AGA AGC TGA AGA CCC TCT G3`; 
anti-sense: 5`TCA TTC ATG GCC TTG TAG ACA C3`; and 18S 
(NM 213557.1), sense: 5`ACCAGTTCGCCATGGATGA3`; 
anti-sense: 5`TGCCGGAGCCGTTGTC3`. 
The gene expression was quantified by real-time PCR 
(Higuchi et al21) using a 7500 Fast Real-Time PCR (Applied 
Biosystems, USA) machine and a Syber Green kit as 
fluorescence markers (number 11744-500, Invitrogen, USA). 
Reactions were performed in 25µl of a mixture containing 
1µl of cDNA sample, 0.5 µl of primers (adjusted to the 
concentration shown below), 10.5 µl of Depec water, and 
12.5 µl of Syber green master mix (dNTP - reaction buffer, 
Taq DNA polymerase Syber green I). The conditions of real-
time PCR were: first cycle (single), at 95°C, for 15 minutes to 
activate the enzyme; 40 cycles with denaturation phases, at 
95°C, for 15 seconds; and annealing, at 60°C, for 30 seconds. 
We used the primer sequence according to the following 
concentrations: 
• soleus muscle: TNF-α and IL-10 (200 nM) and 18S 
(300 nM). 
• EDL - TNF-α: IL-10 (200 nM) and 18S (200 nM). 
Statistical analysis 
Data analysis was performed using the software SigmaStat 
(version 3.1, SigmaStat, Systat, Point Richmond, CA). The 
mean and standard error of the mean (SEM) were calculated 
for all variables. After the trial period, the values of the different 
analyses of the results were performed by unpaired Student’s 
t-test. The level of significance used in all tests was less than 
5%, i.e., p <0.05.
Results 
General characteristics of the experimental groups 
The postoperative mortality was 23.8% (n = 5 animals that 
evolved to death during the 24 hours after surgery) in the MI 
group, and 13.3% (n = 2) in the sham group. The total weight 
of the lungs, liver, soleus and EDL, in absolute value, was not 
different in any of the groups evaluated (Table 1). The MI group 
showed a 23.8% (p <0.012) increase in the absolute heart 
weight when compared to the sham group. The animals with 
MI showed an increase in the wet weight/dry weight ratio of 
the lungs (4.7%, p <0.011), of the liver (3.8, p <0.035), and 
a 27.7% (p <0.002) decrease in the soleus muscle weight 
relative to the body weight (Table 2).
Left ventricular function in animals with MI
In the 17 animals with MI, we observed segmental 
contractile alterations in ventricular pathological studies, 4 
weeks after surgery (Table 3). No animals of the sham group 
had abnormal left ventricular echocardiographic changes 
suggestive of MI. The ejection fraction (EF) and the systolic 
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Absolute weight (g) Sham (13) MI (17)
Body 319,3±17,9 346,2±20,1
Heart 0,90±0,02 1,12±0,06
Liver 7,66±0,50 7,52±0,79
Lung 4,22±0,08 4,41±0,14
Soleus 0,136±0,01 0,132±0,01
EDL 0,150±0,01 0,144±0,01
Note: The results are expressed in grams and represent mean ± SEM of 30 
animals. * Significant difference in comparison with the sham group, p <0.05 
(Student t test). 
Table 1 - Total body weight and total tissue weight in rats that 
underwent sham operation and operation with acute myocardial 
infarction produced by coronary artery ligation after 12 weeks
Relative weight Sham (13) MI (17)
Heart (mg/g) 2,99±0,16 3,24±0,16
Liver (sec. x umi.) 3,04±0,03 3,15±0,03*
Lung (sec. x umi.) 4,22±0,08 4,41±0,14*
Soleus (mg/g) 0,44±0,02 0,35±0,02*
EDL (mg/g) 0,42±0,01 0,43±0,01
Table 2 - Total relative tissue weight in rats that underwent sham 
operation and operation with acute myocardial infarction produced 
by coronary artery ligation after 12 weeks
Note: The results are expressed as values relative to total body weight, 
wet weight (umi.) by dry weight (sec.) and represent mean ± SEM of 30 
animals. * Significant difference in comparision with the sham group, p 
<0.05 (Student t test). 
Parameters Sham (13) MI (17)
EF (%) 67,4±0,10 40,4±0,06*
SF (mm/s) 43,0±3,0 19,5±6,5*
PAVED (mm) 7,73±0,32 10,06±0,77*
EDV (mL) 1,69±0,32 3,08±1,48*
MI (%) 39%±0,05
Table 3 - Values of the functional variables of the left ventricle by 
Doppler echocardiography after 4 weeks in rats that underwent 
sham operation and operation with acute myocardial infarction 
produced by coronary artery ligation (MI)
EF - ejection fraction, SF - shortening fraction, Paved - anterior wall of the left 
ventricle during diastole, EDV - end diastolic volume and MI - index of myocardial 
infarction. The results represent mean ± SEM of 30 animals. * Significant 
difference in comparison  with the sham group, p <0.05 (Student t test).
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Figure 1 - Quantification of IL-10 and TNF-α in the soleus muscle in rats that 
underwent sham operation and operation with acute myocardial infarction 
produced by coronary artery ligation after 12 weeks. The cytokine content was 
analyzed by ELISA and normalized by the total protein content of the tissues 
evaluated. The results represent mean ± SEM of 14 animals. * Significant 
difference in comparison with the sham group, p <0.05 (Student t test).
shortening fraction (SF) showed a 40.1% and a 55.7% (p 
<0.001) reductions, respectively, when these results were 
compared with those obtained in the sham group. The end 
diastolic volume (EDV) increased by 82.2% (p <0.01) when 
compared to that obtained in the sham group. The animals in 
the MI group had an infarct area of 39 ± 0.05%.
TNF-α levels in skeletal muscle 
The MI group animals showed a significant 26.5% increase 
(p <0.05) in the production of TNF-α in the soleus muscle 
when compared to the sham group (Fig. 1). In EDL muscle, 
the levels of TNF-α were not detected. The animals in the 
MI group (Fig. 2A) showed a significant 3-fold  increase (p 
<0.01) in TNF-α gene expression in the soleus muscle, with 
no change in the EDL muscle (Fig. 2B).
IL-10 levels in skeletal muscle 
The MI group animals showed a significant 38.2% decrease 
(p <0.05) of  production of IL-10 in the soleus muscle, when 
compared to the sham-S group (Fig. 1). In the EDL muscle, 
there was no change in the levels of this cytokine. The animals 
in the MI group (Fig. 2A) showed a significant 3.6-fold  increase 
(p <0.05) in IL-10 gene expression in the soleus muscle, with 
no  change in the EDL muscle (Fig. 2B). 
IL-10/TNF-α ratio in skeletal muscle 
The MI group animals showed a significant 36.5% decrease 
(p <0.05) in the IL-10/TNF-α ratio when compared to the 
sham group. The chart 3B data show the participation of each 
cytokine in the IL-10/TNF-α ratio.
Discussion
In this study, the concentration of pro-inflammatory 
cytokine (TNF-α) and its gene expression were increased in the 
soleus muscle of animals with ventricular dysfunction after MI. 
This was observed only in the soleus muscle, and no change 
was detected in the EDL muscle. Furthermore, these changes 
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Figure 2 - IL-10 and TNF-α gene expression in the soleus muscle (A) and in 
the EDL muscle (B) in rats that underwent sham operation and operation with 
acute myocardial infarction produced by ligation of coronary artery after 12 
weeks. The mRNA expression was analyzed by real-time PCR. The results 
represent mean ± SEM, in duplicates of 14 animals. * Significant difference 
in comparison with the sham group, p <0.05 (Student t test). 
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were accompanied by a reduction in the concentration of 
anti-inflammatory cytokine (IL-10) levels, also observed only in 
the soleus muscle,  in turn, the IL-10/TNF-α  ratio was altered, 
suggesting the predominance of TNF-α to the detriment of 
IL-10 in that tissue.
The ligation of the left anterior descending coronary 
artery was used as an experimental model of MI in animals, 
by the induction of myocardial ischemia, with or without 
reperfusion7,22,23. However, data on left ventricular function 
are insufficient for the clinical characterization of HF, because 
this syndrome is defined by the presence of hemodynamic 
abnormalities, fluid retention (congestion), and physical 
exercise intolerance24,25. Although our study showed data 
referring to the congestive picture, such as the dry weight/ wet 
weight ratio of liver and lungs, which suggests the presence 
of pulmonary edema and hepatic congestion, we chose to 
classify the MI group as animals with severe ventricular post-
MI, and not with HF. It is possible that most of the animals in 
the MI group also had HF clinical changes, but this has not 
been studied in this paper.
Initially, it was assumed that the production of TNF-α 
was performed by monocytes and macrophages exclusively 
when appropriately stimulated26. Recently, TNF-α gene and 
protein expression in skeletal muscle has been characterized in 
humans27, in a study that showed for the first time the presence 
of this cytokine in the absence of infiltrating monocytes and 
Figure 3 - Cytokine levels ratio (A) and profile of cytokine levels (B) in the 
muscle IL-10/TNF-α ratio. The cytokine content was analyzed by ELISA and 
normalized by the total protein content of the tissues evaluated. The proportion 
refers to the percentage of each cytokine in the ratio. The results represent 
mean ± SEM of 14 animals. * Significant difference in comparison with the 
sham group, p <0.05 (Student t-test). 
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macrophages. This indicated that the skeletal muscle fiber 
itself can produce it, and so it could act in an autocrine and 
paracrine manner, in sufficient quantity to mediate a series of 
morphological and functional changes in the tissue3,28.
In our study, rats with left ventricular dysfunction post-MI 
showed an increased content of pro-inflammatory cytokine 
TNF-α, which was only evident in the soleus muscle, with 
no change in the EDL muscle (not detected by ELISA). This 
condition was evidenced by the increase in TNF-α gene 
expression, suggesting that the increase in the TNF-α protein 
content may have been due to increased levels of mRNA. This 
result is consistent with another study7 that used the same 
experimental model and demonstrated an increase in both 
gene expression and muscle levels of TNF-α. However, these 
parameters were assessed in the quadriceps muscle, which is 
mixed with regard to its muscle fiber type. 
Therefore, despite the fact that an increase in inflammatory 
mediators (TNF-α, IL-1 β, IL-6) in skeletal muscle is well 
characterized both in patients with HF15 and in rats with 
heart failure and left ventricular dysfunction post-MI7, both 
tests were performed in the quadriceps muscle, and little is 
known about what type of muscle fiber is more affected in 
HF. This becomes even more evident when one takes into 
account that, in addition to the fact that these degenerative 
changes in skeletal muscle have been related to the presence 
of these markers, most studies have also shown that, in 
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HF, the most affected fiber, both morphologically and 
functionally, is the type I fiber3. Thus, we showed, for the 
first time, that this condition appears to be specific to muscle 
tissue with a predominance of type I fibers. As we did not 
separate the total homogenate in a soluble fraction bound 
to the cell membrane, we could not infer that the protein 
assessed was the one which was produced exclusively by 
the tissue evaluated. 
Plasma levels of these cytokines in patients with HF have 
been related to both prognosis and severity of the disease, 
a fact which has been shown to be even more evident in 
patients with more advanced HF (functional class IV, NYHA)6,29. 
Therefore, it has been suggested that this increase results from 
a peripheral inflammatory process, which would ideally be 
initiated in skeletal muscle, because of reduced blood flow 
and a consequent increase in reactive oxygen species5. This 
hypothesis has gained consistency, as studies conducted both 
in animals7,12,23,30,31 and humans2,32,33 have shown that the 
increase in local inflammatory milieu occurs independently 
of plasma levels changes, especially in patients in functional 
classes II and III (NYHA). Therefore, the increased gene and 
protein expression of these cytokines, even without plasma 
levels changes, confirms the results obtained by studies that 
suggest that local inflammation precedes the increase in 
plasma and may be a more accurate indicator with respect 
to the progression of HF. 
The effects of IL-10 in vivo have been observed in models of 
inflammation, autoimmunity, tolerance and parasitic infections 
in animals34. In mice, IL-10 attenuated the deleterious effects 
induced by lipopolysaccharide (LPS) and SEB (staphylococcal 
enterotoxin B). Furthermore, these effects were correlated with 
decreased TNF-α circulating levels. In macrophages cultured 
in the presence of LPS, besides the increase in  production 
of proinflammatory cytokines, this condition is also followed 
by an increase in IL-10, and TNF-α is an important inducer of 
IL-10 gene expression and production34,35. Therefore, IL-10 is 
the main anti-inflammatory cytokine and plays an important 
role in modulating the production of TNF-α. 
In rats with left ventricular dysfunction post-MI, IL-10 
tissue levels were reduced only in the soleus muscle. In these 
animals, the gene expression was increased in the same tissue, 
showing that perhaps the decrease in its production is not 
related to changes in mRNA expression, at least in this aspect. 
This suggests that the effects of this experimental model in the 
concentration of IL-10 may have been mediated in a post-
transcriptional level, like the production of IL-10 transcriptional 
regulatory elements, such as enhancers and/or mechanisms of 
post-transcriptional control. The last possibility is described in T 
cell clones, which express IL-10, with no detectable changes in 
mRNA levels36. Therefore, a combination of post-transcriptional 
mechanisms and ubiquitination for the expression of IL-10 may 
have a crucial role for this cytokine37. Furthermore, although 
TNF-α can induce IL-10 gene expression34 and consequently 
its protein expression, this effect seems to be dependent on the 
intensity of the inflammatory condition, and thus the increase 
in the IL-10 gene expression could have occurred because of 
a decrease in protein production (mRNA/protein ratio) toward 
the restoration of a balanced condition. 
Therefore, the new fact we present is that there was an 
increase not only in gene expression, but also in protein 
content, in the case of TNF-α, and a decrease in IL-10 
protein, suggesting, in this condition, a tendency towards an 
imbalance in their production. This condition may tend to the 
predominance of a pro-inflammatory milieu at the expense of 
the anti-inflammatory milieu, especially through an increased 
production of TNF-α and a decreased production of IL-10. 
This association was observed by Stumpf et al10 who used the 
IL-10/TNF-α ratio to characterize the pro/anti-inflammatory 
"balance". In this study, patients with HF (NYHA functional 
class III/IV) showed increased levels of TNF-α and decreased 
levels of IL-10 when compared with control subjects (without 
IC) of the same age. 
Although the molecular mechanisms are not well 
characterized, studies using IL-10 as treatment (rhIL-10) 
in humans and in knocked out mice (IL-10-/-) stressed the 
importance of this cytokine in reversing the alterations 
caused by local inflammation, especially those mediated 
by TNF-α10. This result is consistent with ours, since the 
IL-10/TNF-α ratio decreased because of an increase in 
TNF-α and, especially, a decrease in IL-10, suggesting an 
important role of IL - 10 in the local inflammatory "control" 
in the soleus muscle. 
In patients with HF, muscle mass  loss or atrophy of 
begins in the early stages of HF8 development, and this 
is more specifically related to intrinsic changes in skeletal 
muscle3,38 than in those resulting from physical inactivity 
(a more determining factor in women). Recently, it has 
been shown that, in this condition, there is an immune 
activation, especially by inflammatory mediators, which may 
contribute to the development of this condition3,7,8,39. In rats 
with heart failure and left ventricular dysfunction after MI, 
this condition has been reproduced both by the decrease 
in cross-sectional area and by increased production of 
proinflammatory cytokines (quadriceps muscle)7. Similarly, 
our study showed a skeletal muscle weight reduction relative 
to body weight, a condition that proved to be dependent on 
the predominant type of muscle fiber, since it was present 
only in the soleus muscle, with no change in the EDL 
muscle. These changes directly and indirectly affect skeletal 
muscle, and recent studies13,14 in rats with heart failure and 
left ventricular dysfunction after MI showed that muscle 
tissues with predominantly type I fibers (e.g., soleus muscle) 
may be more sensitive to changes that are characteristic of 
this experimental model and that compromise the blood 
and oxygen supply, when compared to tissues in which 
type IIa and IIb fibers are predominant (e.g., EDL muscle). 
Therefore, the changes found in proinflammatory and anti-
inflammatory cytokines have demonstrated the presence 
of a chronic inflammatory state in the soleus muscle, as 
assessed by the IL-10/TNF-α ratio, which was paralleled 
by a reduction in muscle mass, a condition which was only 
observed in muscle tissue with a predominance of type I 
fibers (soleus). 
Also noteworthy is that, unlike the above, our animals still 
had no clear clinical manifestations of HF, suggesting that even 
before the establishment of this syndrome, changes in skeletal 
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